Zeitoun, K., Takayama, K., Michael, M.D. and Bulun, S.E. (1999) Stimulation of Aromatase P450 Promoter (II) Activity in Endometriosis and Its Inhibition in Endometrium Are Regulated by Competitive Binding of SF-1 and COUP-TF to the Same Cis-Acting Element. Molecular Endocrinology, 113, 239-253.
http://dx.doi.org/10.1210/mend.13.2.0229

has been cited by the following article:

• TITLE: Association between mRNA Expression of Aromatase, 17β-HSD2, Level of TGF-β1 and Stage of Endometriosis

  AUTHORS: Ruswana Anwar, Firman F. Wirakusumah, Duddy S. Nataprawira, Ani M. Maskoen, Wiryawan Permadi, Tono Djuwantono

  KEYWORDS: Aromatase, 17βHSD2, TGFβ1, Stage Endometriosis

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.6 No.7, June 16, 2016

  ABSTRACT: Aim: To identify the correlation between mRNA expression of aromatase, 17β-HSD2 level of TGF-β1 and stage of endometriosis. Methods: Case control study was done on 80 patients divided by 40 endometriosis patients and 40 patients as control. mRNA expression of aromatase, mRNA 17β-SD2, was checked using reverse-transcriptase polymerase chain reaction (RT-PCR) and TGF-β1 serum and peritoneal fluid was checked using ELISA. Result: Level of mRNA aromatase from ectopic and eutopic endometrium increased significantly compared to control group (p TGF-β1 on endometriosis group was significantly higher compared to control group (p serum level to endometriosis stage. There are significant correlations between peritoneal fluid TGF-β1 levels to endometriosis stage.